77047-42-8

Basic information

• Product Name: DIETHYL (4-PYRIDINEMETHYL) PHOSPHONATE
• Synonyms: DIETHYL (4-PYRIDINEMETHYL) PHOSPHONATE;Diethyl [(4-pyridinyl)methyl)]phosphonate;Diethyl (pyridin-4-ylmethyl)phosphonate;Diethyl 4-pyridylmethylphosphonate;4-(Diethoxyphosphorylmethyl)pyridine
• CAS NO: 77047-42-8
• Molecular Formula: C₁₀H₁₆NO₃P
• Molecular Weight: 229.21
• Mol File: 77047-42-8.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 89 °C(Press: 0.05 Torr)
• Appearance: /
• Density: 1.135±0.06 g/cm3(Predicted)
• PKA: 5.33±0.10(Predicted)
• CAS DataBase Reference: DIETHYL (4-PYRIDINEMETHYL) PHOSPHONATE(CAS DataBase Reference)
• NIST Chemistry Reference: DIETHYL (4-PYRIDINEMETHYL) PHOSPHONATE(77047-42-8)
• EPA Substance Registry System: DIETHYL (4-PYRIDINEMETHYL) PHOSPHONATE(77047-42-8)

Safety Data

• Hazardous Substances Data: 77047-42-8(Hazardous Substances Data)

Upstream product

• 10445-91-7 4-(Chloromethyl)pyridine 
• 762-04-9 Diethyl phosphonate 
• 762-04-9 phosphonic acid diethyl ester 
• 54751-01-8 4-(bromomethyl)pyridine 
• 122-52-1 triethyl phosphite 
• 1822-51-1 4-picolylchloride hydrochloride 
• 2870-30-6 sodium diethyl phosphate 
• 872-85-5 pyridine-4-carbaldehyde 
• 2459-09-8 4-pyridinecarboxylic acid, methyl ester 
• 586-95-8 pyridine-4-methanol 

Downstream Products

• 117999-80-1 <(1-benzylpyridino)-4-methyl>phosphonic acid 
• 80241-43-6 (4-Pyridylmethyl)phosphonic acid 
• 113229-61-1 cis-4-(phosphonomethyl)piperidine-2-carboxylic acid 
• 1239713-20-2 C₃₉H₃₀N₄ 
• 1415818-83-5 diethyl 3-(N-benzyloxyamino)-1-(pyridin-4-yl)propylphosphonate 
• 1548367-63-0 4-bromo-N,N-bis(4-((E)-2-(pyridin-4-yl)vinyl)phenyl)aniline 
• 1548368-52-0 4-iodo-N,N-bis(4-((E)-2-(pyridin-4-yl)vinyl)phenyl)aniline 

Relevant articles and documents

Orotic acid as a useful supramolecular synthon for the fabrication of an OPV based hydrogel: Stoichiometry dependent injectable behavior

A facile hydrogelation of a p-pyridylenevinylene derivative (PV) bearing oxyethylene chains in the presence of orotic acid (OA) occurs via various non-covalent interactions. Depending on the PV:OA molar ratio, the hydrogel shows vesicle to either cluster-

Antimalarial and structural studies of pyridine-containing inhibitors of 1-deoxyxylulose-5-phosphate reductoisomerase

1-Deoxy-d-xylulose-5-phosphate reductoisomerase (DXR) in the nonmevalonate isoprene biosynthesis pathway is a target for developing antimalarial drugs. Fosmidomycin, a potent DXR inhibitor, showed safety as well as efficacy against Plasmodium falciparum malaria in clinical trials. On the basis of our previous quantitative structure-activity relationship (QSAR) and crystallographic studies, several novel pyridine-containing fosmidomycin derivatives were designed, synthesized, and found to be highly potent inhibitors of P. falciparum DXR (PfDXR) having Ki values of 1.9-13 nM, with the best one being ～11× more active than fosmidomycin. These compounds also potently block the proliferation of multidrug resistant P. falciparum with EC 50 values as low as 170 nM. A 2.3 A? crystal structure of PfDXR in complex with one of the inhibitors is reported, showing that the flexible loop of the protein undergoes conformational changes upon ligand binding and a hydrogen bond and favorable hydrophobic interactions between the pyridine group and the PfDXR account for the enhanced activity.

Substituted 4-aza-5α-androstan-ones as 5α-reductase inhibitors

Described are new 16-substituted and 7,16-disubstituted 4-aza-5α-androstan-3-ones and related compounds as 5α-reductase inhibitors.